Firm drives innovation for treatment of hemophilia patients
4 years ago(FILES) In this file photo a man wearing facemask and shield walks past the Pfizer headquarters in New York on March 11, 2021, one year after the pandemic was officially declared. - Pfizer sharply increased its projections for 2021 revenues and profits on May 4, 2021, citing much higher sales from its Covid-19 vaccine sales.The drugmaker now estimates 2021 revenues of $26 billion from the vaccine, up from $15 billion previously and reflecting 1.6 billion doses expected to be delivered this year under contracts signed through mid-April. (Photo by Kena Betancur / AFP)
Pfizer has said it is working to find innovative solutions for the treatment of patients living with hemophilia. It stated this at a virtual media roundtable at the weekend, to commemorate World Hemophilia Day (WHD).